Comprehensive Analysis of FASN in Tumor Immune Infiltration and Prognostic Value for Immunotherapy and Promoter DNA Methylation.

Int J Mol Sci · 2022 · PMC9779179 · PMID 36555243

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Consistent with the TCGA database expression trend, FASN expression was significantly higher in COAD, UCEC, and PAAD, and demonstrated a decreasing trend in comparison with normal samples in BRCA, ovarian cancer, GBM, liver cancer, and lung cancer ( Figure 1 D).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.